Across TCGA pan-cancer cohorts, RN7SL88P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL88P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL88P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL88P is over-expressed in tumor.
KIRC are the cancer types where RN7SL88P tumor–normal differential expression is most reproducible.